Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Pharmaceutical Business Review
Return to: PBR Home | Companies

Alnylam Pharmaceuticals Inc

Alnylam Pharmaceuticals Inc
3rd Floor
300 Third Street
Cambridge
United States of America
Phone: 1 617 5518200
Fax: 16-17-5518101
www.alnylam.com

No. employees: 514
Turnover: 47.16 (US$m)
Financial year end: December

Company Overview

Top Competitors


Key Employees

Michael W. Bonney

Chairman, Executive Board

John M. Maraganore, Ph.D.

Chief Executive Officer, Director, Executive Board

Dennis A. Ausiello, M.D.

Director, Non Executive Board

Kevin P. Starr

Director, Non Executive Board

Phillip A. Sharp, Ph.D.

Director, Non Executive Board

Steven M. Paul

Director, Non Executive Board

Paul R. Schimmel, Ph.D.

Director, Non Executive Board

Marsha H. Fanucci

Director, Non Executive Board

John K. Clarke

Director, Non Executive Board

David E.I. Pyott

Director, Non Executive Board

Amy W. Schulman

Director, Non Executive Board

Akshay K. Vaishnaw, M.D., Ph.D.

Executive Vice President - Research and Development, Senior Management

Aria Tavana, Ph.D.

Vice President - Quality Assurance, Senior Management

Jeff Cehelsky

Vice President - Clinical Operations, Senior Management

Michael P. Mason

Treasurer, Vice President - Finance, Senior Management

Muthiah Manoharan, Ph.D.

Senior Vice President - Drug Discovery, Senior Management

Barry E. Greene

President, Senior Management

Steve Bossone, Ph.D.

Vice President - Intellectual Property, Senior Management

Eric Green

Vice President, General Manager - TTR Program, Senior Management

Lubomir Nechev, Ph.D.

Vice President - Process Sciences, Senior Management

Jared Gollob, M.D.

Vice President - Clinical Research, Senior Management

Saraswathy Nochur, Ph.D.

Senior Vice President - Regulatory Affairs, Senior Management

Karen Anderson

Senior Vice President, Chief Human Resources Officer, Senior Management

Laurie B. Keating

Senior Vice President, General Counsel, Secretary, Senior Management

Pushkal Garg, M.D.

Chief Medical Officer, Senior Management

Laura Sepp-Lorenzino, Ph.D.

Vice President - Entrepreneur-in-Residence, Senior Management

Pritesh Gandhi

Vice President - Medical Affairs, Senior Management

Mary Beth DeLena

Vice President - Associate General Counsel, Senior Management

Yvonne Greenstreet

Executive Vice President, Chief Operating Officer, Senior Management

Emmanuel Dulac

Senior Vice President, Chief Commercial Officer, Senior Management

Locations/Subsidiaries


3rd Floor,
300 Third Street,
Cambridge,
Massachusetts,
United States of America
Phone: 1 617 5518200
Fax: 1 617 5518101

Alnylam (Bermuda) Ltd.

Bermuda

Alnylam Europe AG

Fritz-Hornschuch-Str. 9,
Kulmbach,
Germany
Phone: 49 9221 827620
Fax: 49 9221 8276299

Alnylam Switzerland GmbH

Switzerland

Alnylam UK Limited

United Kingdom

Alnylam Securities Corporation

300 3rd Street no.3,
Cambridge,
Massachusetts,
United States of America
Phone: 1 617 5518200

Alnylam U.S., Inc.

United States of America

Regulus Therapeutics Inc

10614 Science Center Dr,
SAN DIEGO,
California,
United States of America
Phone: 1 858 2026300
Fax: 1 302 6555049

Sirna Therapeutics Inc (Inactive)

3rd Floor ,
300 Third St ,
Cambridge,
Massachusetts,
United States of America

Products/Services


Products:

  • Pipeline:
  • ALN-TTR02 - transthyretin-mediated amyloidosis (ATTR)
  • ALN-TTRsc - ATTR in patients with TTR cardiac amyloidosis
  • ALN-AT3 - hemophilia and rare bleeding disorders
  • ALN-CC5 - complement-mediated diseases
  • ALN-AS1 - hepatic porphyrias
  • ALN-PCSsc - hypercholesterolemia
  • ALN-AAT - AAT deficiency liver disease
  • ALN-TMP - beta-thalassemia and iron-overload disorders
  • ALN-ANG - genetic forms of mixed hyperlipidemia and severe hypertriglyceridemia
  • Partner Programs:
  • ALN-RSV - Respiratory Syncytial Virus (RSV) infection
  • ALN-VSP - advanced stage solid tumors in the liver

Services:

  • Alnylam Assist